Our functional study using knockdown and inhibitor FSG67 confirmed the pro-inflammatory effect of GPAT3 in vitro; that is, deleting GPAT3 significantly inhibited LPS-induced KCs inflammation. The gene discussed is GPAT3; the disease is dry eye syndrome.